ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
CERo Therapeutics Holdings Inc

CERo Therapeutics Holdings Inc (CERO)

2.00
-0.14
(-6.54%)
終値: 2月4日 6:00AM
1.96
-0.04
( -2.00% )
取引時間後: 7:16AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
1.96
買値
1.96
売値
1.98
出来高
231,122
1.98 日の範囲 2.15
1.76 52 週間の範囲 1,238.00
前日終値
2.14
始値
2.035
最終取引時間
07:25:04
平均取引量 (3 か月)
102,152,311
財務取引量
US$ 474,838
VWAP
2.0545

CERO 最新ニュース

CERo Therapeutics Holdings, Inc. Announces Reverse Stock Split

SOUTH SAN FRANSCISCO, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance...

CERo Therapeutics, Inc. Appoints Chris Ehrlich CEO

SOUTH SAN FRANCISCO, Calif, Dec. 06, 2024 (GLOBE NEWSWIRE) --   CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy company seeking to advance the next...

CERo Therapeutics, Inc. Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Its Lead Compound CER-1236 in Acute Myelogenous Leukemia

SOUTH SAN FRANCISCO, Calif, Nov. 15, 2024 (GLOBE NEWSWIRE) --  CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy company seeking to advance the next...

CERo Therapeutics, Inc. Presents Preclinical Data Demonstrating CER-1236 Killing Ovarian Cancer Cell Lines Without Toxicity

Data presented as part of a poster at the SITC 2024 Conference SOUTH SAN FRANCISCO, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) --  CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an...

CERo Therapeutics, Inc. Provides Corporate Update

Company announces submission of IND Clinical Hold Complete Response Letter SOUTH SAN FRANCISCO, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO...

CERo Therapeutics, Inc. Names Al Kucharchuk Chief Financial Officer and Kristen Pierce Chief Development Officer

SOUTH SAN FRANCISCO, Calif, Oct. 02, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy company seeking to advance the next generation...

CERo Therapeutics, Inc. Announces Financing and Provides Update on Investigational New Drug Application for CER-1236

Company requests Type A Meeting with U.S. Food and Drug Administration regarding clinical hold for CER-1236; announces key management changes SOUTH SAN FRANCISCO, Calif., Sept. 25, 2024 (GLOBE...

CERo Therapeutics, Inc. Presents CER-1236 Data Supporting Use in AML at Global Cell & Gene Therapy Summit 2024

Company anticipates initial human trials to focus on AML upon IND clearance SOUTH SAN FRANCISCO, Calif., July 08, 2024 (GLOBE NEWSWIRE) --  CERo Therapeutics Holdings, Inc. (Nasdaq: CERO...

CERo Therapeutics, Inc. Completes IND-Enabling Activities Following Successful Manufacturing Runs for Lead Compound CER-1236

Company anticipates near term filing of Investigational New Drug Application to FDA SOUTH SAN FRANCISCO, Calif., June 13, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq:...

CERo Therapeutics, Inc. Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236

Company continuing IND-enabling activities in preparation for submission of Investigational New Drug Application to FDA SOUTH SAN FRANCISCO, Calif., June 06, 2024 (GLOBE NEWSWIRE) --  CERo...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.29-12.88888888892.253.181.7615700251.97076636CS
4-2.87-59.42028985514.8310.251.76602128405.08306231CS
12-17.32-89.834024896319.2844.771.7610215231117.71399823CS
26-12.14-86.099290780114.144.771.764993592417.05719778CS
52-523.04-99.626666666752512381.762722237720.43757397CS
156-523.04-99.626666666752512381.762722237720.43757397CS
260-523.04-99.626666666752512381.762722237720.43757397CS

CERO - Frequently Asked Questions (FAQ)

What is the current CERo Therapeutics share price?
The current share price of CERo Therapeutics is US$ 1.96
What is the 1 year trading range for CERo Therapeutics share price?
CERo Therapeutics has traded in the range of US$ 1.76 to US$ 1,238.00 during the past year

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
PTIRGraniteShares 2X Long PLTR Daily ETF
US$ 225.34
(45.09%)
342.91k
PLTUDirexion DAily PLTR Bull 2X Shares
US$ 47.77
(44.80%)
559.92k
PLTRPalantir Technologies Inc
US$ 102.89
(22.87%)
30.61M
EVAXEvaxion Biotech AS
US$ 2.89
(20.42%)
3.26M
SMCXDefiance Daily Target 2X Long SMCI ETF
US$ 33.585
(19.69%)
122.86k
UOKAMDJM Ltd
US$ 0.178
(-25.21%)
2.82M
UPCUniverse Pharmaceuticals Inc
US$ 0.3167
(-24.13%)
419.25k
BCTXBriaCell Therapeutics Corporation
US$ 3.86
(-23.41%)
298.28k
PLTDDirexion Daily PLTR Bear 1X Shares
US$ 15.85
(-22.61%)
936.43k
EJHE Home Household Service Holdings Ltd
US$ 0.7915
(-22.40%)
537.73k
PLTRPalantir Technologies Inc
US$ 102.8217
(22.79%)
30.61M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0399
(-13.64%)
13.84M
IVVDInvivyd Inc
US$ 1.00
(-5.66%)
8.86M
NVDANVIDIA Corporation
US$ 118.00
(1.15%)
6.87M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.1939
(-0.51%)
5.27M

CERO Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock